EGFR and gastric cancer: MT inhibits gastric cancer cell proliferation in a dose-dependent manner by arresting cells in the G1 phase; it significantly inhibits gastric cancer cell migration and invasion by inhibiting EGFR phosphorylation (Guo et al., 2015).